Thyrocare Technologies Limited

NSEI:THYROCARE 주식 보고서

시가총액: ₹34.3b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Thyrocare Technologies 관리

관리 기준 확인 0/4

Thyrocare Technologies' CEO는 Rahul Guha, May2022 에 임명되었습니다 의 임기는 2.08 년입니다. 는 ₹ 33.49M 가치에 해당하는 회사 주식의 0.099% 직접 소유합니다. 33.49M. 경영진과 이사회의 평균 재임 기간은 각각 1.5 년과 2.8 년입니다.

주요 정보

Rahul Guha

최고 경영자

₹31.8m

총 보상

CEO 급여 비율n/a
CEO 임기2.1yrs
CEO 소유권0.1%
경영진 평균 재임 기간1.5yrs
이사회 평균 재임 기간2.8yrs

최근 관리 업데이트

Recent updates

A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Jun 12
A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Feb 29
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 04
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Dec 08
Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 08
Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Mar 23
Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Mar 02
Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Feb 01
Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

Jan 12
Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Dec 24
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Dec 17
Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 30
Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Nov 02
Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

Nov 01
Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?

Oct 28
How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?

Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares

Oct 07
Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares

The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More

Sep 29
The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More

Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?

Sep 11
Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?

Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares

Aug 22
Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares

Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings

Aug 17
Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings

Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Jul 30
Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking

Jul 28
Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking

Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jul 04
Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

CEO

Rahul Guha (46 yo)

2.1yrs

테뉴어

₹31,801,079

보상

Mr. Rahul Franklin Guha is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 2022 and also serves as its Chairman since April 07, 2023. He joined the Th...


리더십 팀

이름위치테뉴어보상소유권
Rahul Guha
MD, CEO & Chairman2.1yrs₹31.80m0.099%
₹ 34.0m
K. KallathiKumar
Chief Operating Officerno data₹9.89m0.0030%
₹ 1.0m
Ramjee Dorai
Company Secretary & Compliance Officer9.8yrs₹3.09m0.040%
₹ 13.7m
Aditya Shinde
Vice Presidentno data₹5.33m0.0020%
₹ 686.2k
Alok Jagnani
Chief Financial Officerless than a year데이터 없음0%
₹ 0
Pratik Hire
Head of Strategy & Investor Relationsno data데이터 없음데이터 없음
Nitin Chugh
Chief Commercial Officerless than a year데이터 없음데이터 없음

1.5yrs

평균 재임 기간

46yo

평균 연령

경험이 풍부한 관리: THYROCARE 의 관리팀은 경험 (평균 재직 기간 1.5 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Rahul Guha
MD, CEO & Chairman2.1yrs₹31.80m0.099%
₹ 34.0m
Gopal Krishna Hegde
Independent Non-Executive Director9.8yrs₹160.00k데이터 없음
Neetin Desai
Independent Non-Executive Director9.8yrs₹50.00k데이터 없음
Indumati Gopinathan
Non-Executive Independent Director6.8yrs₹70.00k데이터 없음
Dharmil Sheth
Non-Executive & Non-Independent Director2.8yrs데이터 없음데이터 없음
Hardik Dedhia
Non Executive Director2.8yrs데이터 없음데이터 없음
Dhaval Shah
Non Executive Director2.7yrs데이터 없음데이터 없음
Prapti Gilada
Independent Directorless than a year데이터 없음데이터 없음
Harshil Vora
Non-Executive Independent Directorless than a year데이터 없음데이터 없음

2.8yrs

평균 재임 기간

36yo

평균 연령

경험이 풍부한 이사회: THYROCARE 의 이사회경험(평균 재직 기간 2.8 년)으로 간주되지 않으므로 새 이사회가 필요합니다.